Avanos Non Currrent Assets Other from 2010 to 2024
AVNS Stock | USD 20.20 0.24 1.20% |
Non Currrent Assets Other | First Reported 2013-12-31 | Previous Quarter 19.3 M | Current Value 19.1 M | Quarterly Volatility 7.9 M |
Check Avanos Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avanos main balance sheet or income statement drivers, such as Depreciation And Amortization of 43.6 M, Interest Expense of 16.1 M or Selling General Administrative of 286.2 M, as well as many exotic indicators such as Price To Sales Ratio of 1.49, Dividend Yield of 0.26 or PTB Ratio of 1.45. Avanos financial statements analysis is a perfect complement when working with Avanos Medical Valuation or Volatility modules.
Avanos | Non Currrent Assets Other |
Latest Avanos Medical's Non Currrent Assets Other Growth Pattern
Below is the plot of the Non Currrent Assets Other of Avanos Medical over the last few years. It is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. Avanos Medical's Non Currrent Assets Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Avanos Medical's overall financial position and show how it may be relating to other accounts over time.
Non Currrent Assets Other | 10 Years Trend |
|
Non Currrent Assets Other |
Timeline |
Avanos Non Currrent Assets Other Regression Statistics
Arithmetic Mean | 10,046,611 | |
Geometric Mean | 7,347,905 | |
Coefficient Of Variation | 80.96 | |
Mean Deviation | 6,489,718 | |
Median | 7,600,000 | |
Standard Deviation | 8,133,239 | |
Sample Variance | 66.1T | |
Range | 28.5M | |
R-Value | 0.47 | |
Mean Square Error | 55.5T | |
R-Squared | 0.22 | |
Significance | 0.08 | |
Slope | 854,622 | |
Total Sum of Squares | 926.1T |
Avanos Non Currrent Assets Other History
About Avanos Medical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Avanos Medical income statement, its balance sheet, and the statement of cash flows. Avanos Medical investors use historical funamental indicators, such as Avanos Medical's Non Currrent Assets Other, to determine how well the company is positioned to perform in the future. Although Avanos Medical investors may use each financial statement separately, they are all related. The changes in Avanos Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Avanos Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Avanos Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Avanos Medical. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Non Currrent Assets Other | 19.3 M | 12 M |
Pair Trading with Avanos Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avanos Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avanos Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with Avanos Stock
0.68 | GH | Guardant Health Earnings Call Tomorrow | PairCorr |
Moving against Avanos Stock
0.6 | DYNT | Dynatronics Fiscal Year End 26th of September 2024 | PairCorr |
The ability to find closely correlated positions to Avanos Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avanos Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avanos Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avanos Medical to buy it.
The correlation of Avanos Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avanos Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avanos Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Avanos Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Avanos Medical Correlation against competitors. For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Avanos Stock analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Avanos Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avanos Medical. If investors know Avanos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avanos Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.38) | Earnings Share (0.03) | Revenue Per Share 14.626 | Quarterly Revenue Growth 0.043 | Return On Assets 0.0218 |
The market value of Avanos Medical is measured differently than its book value, which is the value of Avanos that is recorded on the company's balance sheet. Investors also form their own opinion of Avanos Medical's value that differs from its market value or its book value, called intrinsic value, which is Avanos Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avanos Medical's market value can be influenced by many factors that don't directly affect Avanos Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avanos Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avanos Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avanos Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.